Rebecca Kathryn McHugh, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Opioid-Related Disorders | 46 | 2024 | 2160 | 6.660 |
Why?
|
Substance-Related Disorders | 42 | 2024 | 4419 | 6.010 |
Why?
|
Alcoholism | 12 | 2024 | 1973 | 3.030 |
Why?
|
Anxiety Disorders | 17 | 2024 | 2717 | 2.340 |
Why?
|
Stress, Psychological | 17 | 2024 | 4477 | 2.120 |
Why?
|
Anxiety | 26 | 2022 | 4571 | 2.030 |
Why?
|
Catastrophization | 5 | 2020 | 348 | 1.990 |
Why?
|
Benzodiazepines | 11 | 2022 | 1132 | 1.890 |
Why?
|
Analgesics, Opioid | 25 | 2024 | 3801 | 1.850 |
Why?
|
Tranquilizing Agents | 3 | 2022 | 58 | 1.630 |
Why?
|
Alcohol-Related Disorders | 4 | 2023 | 238 | 1.250 |
Why?
|
Behavior Therapy | 6 | 2024 | 880 | 1.110 |
Why?
|
Motivation | 6 | 2024 | 2006 | 1.070 |
Why?
|
Sex Factors | 14 | 2024 | 10551 | 1.070 |
Why?
|
Heroin Dependence | 3 | 2016 | 172 | 1.060 |
Why?
|
Hypnotics and Sedatives | 5 | 2024 | 1178 | 1.050 |
Why?
|
Cues | 6 | 2022 | 875 | 1.040 |
Why?
|
Psychotherapy | 7 | 2020 | 1647 | 1.000 |
Why?
|
Sex Characteristics | 8 | 2024 | 2637 | 0.970 |
Why?
|
Personality Inventory | 3 | 2012 | 1019 | 0.910 |
Why?
|
Affect | 5 | 2024 | 1485 | 0.850 |
Why?
|
Comprehension | 4 | 2013 | 621 | 0.840 |
Why?
|
Adaptation, Psychological | 10 | 2024 | 2630 | 0.830 |
Why?
|
Heroin | 3 | 2021 | 119 | 0.820 |
Why?
|
Adult | 85 | 2024 | 221122 | 0.780 |
Why?
|
Substance Withdrawal Syndrome | 6 | 2018 | 625 | 0.770 |
Why?
|
Methamphetamine | 1 | 2023 | 165 | 0.770 |
Why?
|
Psychotherapy, Group | 4 | 2021 | 412 | 0.730 |
Why?
|
Self Report | 12 | 2020 | 3724 | 0.710 |
Why?
|
Depressive Disorder | 6 | 2019 | 3728 | 0.690 |
Why?
|
Narcotic Antagonists | 6 | 2022 | 585 | 0.670 |
Why?
|
Health Surveys | 3 | 2024 | 4059 | 0.630 |
Why?
|
Evidence-Based Practice | 4 | 2020 | 495 | 0.630 |
Why?
|
Patient Dropouts | 3 | 2020 | 412 | 0.620 |
Why?
|
Humans | 138 | 2024 | 761326 | 0.620 |
Why?
|
Psychometrics | 9 | 2023 | 3064 | 0.600 |
Why?
|
Male | 85 | 2025 | 360621 | 0.580 |
Why?
|
Buprenorphine | 3 | 2022 | 655 | 0.570 |
Why?
|
Female | 88 | 2024 | 392485 | 0.570 |
Why?
|
Panic Disorder | 3 | 2010 | 613 | 0.550 |
Why?
|
Spiritual Therapies | 1 | 2017 | 60 | 0.550 |
Why?
|
Young Adult | 39 | 2024 | 59196 | 0.540 |
Why?
|
Online Systems | 1 | 2017 | 182 | 0.530 |
Why?
|
Alcohol Deterrents | 1 | 2016 | 49 | 0.520 |
Why?
|
Behavior, Addictive | 3 | 2016 | 462 | 0.510 |
Why?
|
Implosive Therapy | 1 | 2017 | 125 | 0.510 |
Why?
|
Irritable Mood | 1 | 2016 | 194 | 0.500 |
Why?
|
Prevalence | 11 | 2023 | 15719 | 0.500 |
Why?
|
Self Efficacy | 1 | 2019 | 637 | 0.500 |
Why?
|
Depression | 8 | 2020 | 8122 | 0.500 |
Why?
|
Prejudice | 1 | 2019 | 570 | 0.500 |
Why?
|
Cocaine | 1 | 2020 | 958 | 0.500 |
Why?
|
Opiate Substitution Treatment | 9 | 2022 | 443 | 0.490 |
Why?
|
Central Nervous System Stimulants | 2 | 2023 | 1176 | 0.490 |
Why?
|
Counseling | 7 | 2021 | 1546 | 0.490 |
Why?
|
Substance Abuse Treatment Centers | 3 | 2014 | 166 | 0.490 |
Why?
|
Mental Disorders | 5 | 2014 | 6839 | 0.480 |
Why?
|
Epidemics | 1 | 2020 | 511 | 0.470 |
Why?
|
Severity of Illness Index | 9 | 2023 | 15835 | 0.460 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2020 | 4014 | 0.460 |
Why?
|
Middle Aged | 53 | 2024 | 220774 | 0.460 |
Why?
|
Psychiatric Status Rating Scales | 11 | 2017 | 6019 | 0.460 |
Why?
|
Religion | 1 | 2017 | 372 | 0.460 |
Why?
|
Smoking Cessation | 3 | 2016 | 2056 | 0.450 |
Why?
|
Outpatients | 5 | 2021 | 1596 | 0.440 |
Why?
|
Attention | 4 | 2010 | 2395 | 0.430 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1088 | 0.430 |
Why?
|
Factor Analysis, Statistical | 3 | 2023 | 999 | 0.420 |
Why?
|
Dreams | 1 | 2014 | 146 | 0.410 |
Why?
|
Stress Disorders, Post-Traumatic | 3 | 2024 | 4579 | 0.410 |
Why?
|
Information Dissemination | 3 | 2011 | 1127 | 0.400 |
Why?
|
Patient Satisfaction | 4 | 2024 | 3460 | 0.400 |
Why?
|
Pain Threshold | 1 | 2016 | 603 | 0.390 |
Why?
|
Prescription Drugs | 1 | 2019 | 631 | 0.390 |
Why?
|
Adolescent | 24 | 2024 | 88305 | 0.370 |
Why?
|
Psychological Tests | 3 | 2014 | 640 | 0.370 |
Why?
|
United States | 20 | 2024 | 72317 | 0.370 |
Why?
|
Perception | 1 | 2017 | 1197 | 0.350 |
Why?
|
Psychotropic Drugs | 2 | 2013 | 888 | 0.350 |
Why?
|
Reading | 1 | 2014 | 529 | 0.350 |
Why?
|
Public Policy | 1 | 2014 | 559 | 0.350 |
Why?
|
CA1 Region, Hippocampal | 2 | 2022 | 110 | 0.350 |
Why?
|
Hydrocortisone | 2 | 2024 | 1815 | 0.340 |
Why?
|
Cocaine-Related Disorders | 3 | 2024 | 461 | 0.330 |
Why?
|
Health Literacy | 1 | 2014 | 444 | 0.310 |
Why?
|
Protein Biosynthesis | 1 | 2016 | 2114 | 0.310 |
Why?
|
Alcohol Drinking | 2 | 2023 | 4027 | 0.300 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2010 | 324 | 0.300 |
Why?
|
Pilot Projects | 6 | 2024 | 8632 | 0.300 |
Why?
|
Imipramine | 1 | 2007 | 98 | 0.290 |
Why?
|
Attitude to Health | 1 | 2016 | 2025 | 0.290 |
Why?
|
Therapy, Computer-Assisted | 3 | 2014 | 266 | 0.290 |
Why?
|
Diffusion of Innovation | 3 | 2014 | 727 | 0.280 |
Why?
|
Models, Psychological | 4 | 2023 | 828 | 0.280 |
Why?
|
Rats, Long-Evans | 2 | 2025 | 383 | 0.270 |
Why?
|
Paroxetine | 1 | 2007 | 182 | 0.270 |
Why?
|
Risk-Taking | 1 | 2012 | 1037 | 0.270 |
Why?
|
Treatment Outcome | 21 | 2024 | 64645 | 0.270 |
Why?
|
Drug Therapy | 1 | 2009 | 503 | 0.270 |
Why?
|
Borderline Personality Disorder | 1 | 2013 | 768 | 0.260 |
Why?
|
Feasibility Studies | 3 | 2024 | 5247 | 0.260 |
Why?
|
Patient Preference | 1 | 2013 | 926 | 0.250 |
Why?
|
Sleep Initiation and Maintenance Disorders | 2 | 2018 | 1081 | 0.250 |
Why?
|
Models, Theoretical | 1 | 2017 | 3577 | 0.250 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2007 | 431 | 0.250 |
Why?
|
Neoplasms | 2 | 2024 | 22158 | 0.240 |
Why?
|
Drug Prescriptions | 1 | 2014 | 1669 | 0.240 |
Why?
|
Cytoskeletal Proteins | 2 | 2022 | 1342 | 0.240 |
Why?
|
Anti-Anxiety Agents | 2 | 2018 | 397 | 0.240 |
Why?
|
Impulsive Behavior | 2 | 2021 | 346 | 0.240 |
Why?
|
Saliva | 2 | 2024 | 827 | 0.240 |
Why?
|
Wounds and Injuries | 1 | 2017 | 2490 | 0.240 |
Why?
|
Women's Health | 1 | 2014 | 2065 | 0.240 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2007 | 489 | 0.230 |
Why?
|
Cycloserine | 3 | 2010 | 118 | 0.220 |
Why?
|
Smoking | 4 | 2020 | 9051 | 0.220 |
Why?
|
Combined Modality Therapy | 4 | 2010 | 8526 | 0.220 |
Why?
|
Reproducibility of Results | 8 | 2023 | 20092 | 0.210 |
Why?
|
Photic Stimulation | 3 | 2016 | 1985 | 0.210 |
Why?
|
Stress, Physiological | 1 | 2010 | 1403 | 0.210 |
Why?
|
Patient Acceptance of Health Care | 2 | 2013 | 3204 | 0.210 |
Why?
|
Methadone | 4 | 2020 | 321 | 0.200 |
Why?
|
Galvanic Skin Response | 1 | 2024 | 357 | 0.200 |
Why?
|
Sexual Behavior | 1 | 2012 | 2179 | 0.200 |
Why?
|
Comorbidity | 6 | 2024 | 10498 | 0.190 |
Why?
|
National Institute on Drug Abuse (U.S.) | 1 | 2021 | 11 | 0.190 |
Why?
|
Age Factors | 6 | 2024 | 18401 | 0.190 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2024 | 10203 | 0.190 |
Why?
|
Marijuana Abuse | 2 | 2024 | 411 | 0.190 |
Why?
|
Publication Bias | 2 | 2013 | 160 | 0.180 |
Why?
|
Research Design | 4 | 2022 | 6178 | 0.180 |
Why?
|
Suicide | 2 | 2022 | 1598 | 0.180 |
Why?
|
Inpatients | 3 | 2023 | 2548 | 0.180 |
Why?
|
Delphi Technique | 2 | 2022 | 846 | 0.180 |
Why?
|
Cross-Sectional Studies | 7 | 2022 | 26108 | 0.170 |
Why?
|
Patient Compliance | 2 | 2014 | 2690 | 0.170 |
Why?
|
Pregnancy Complications | 1 | 2014 | 2947 | 0.170 |
Why?
|
Hospitals | 1 | 2013 | 3878 | 0.170 |
Why?
|
Analysis of Variance | 3 | 2017 | 6231 | 0.170 |
Why?
|
Pain Measurement | 4 | 2019 | 3552 | 0.170 |
Why?
|
Aged | 17 | 2024 | 169179 | 0.170 |
Why?
|
Pain | 4 | 2022 | 5077 | 0.170 |
Why?
|
Spirituality | 1 | 2024 | 425 | 0.160 |
Why?
|
Personal Satisfaction | 1 | 2023 | 642 | 0.150 |
Why?
|
Nerve Tissue Proteins | 2 | 2022 | 4414 | 0.150 |
Why?
|
Maze Learning | 1 | 2019 | 482 | 0.150 |
Why?
|
Evidence-Based Medicine | 1 | 2009 | 3687 | 0.140 |
Why?
|
Hospitals, Private | 1 | 2017 | 63 | 0.140 |
Why?
|
Fear | 5 | 2025 | 1476 | 0.140 |
Why?
|
Adult Survivors of Child Abuse | 1 | 2020 | 294 | 0.140 |
Why?
|
Public Health | 2 | 2020 | 2667 | 0.130 |
Why?
|
Sex Offenses | 1 | 2020 | 352 | 0.130 |
Why?
|
Hospitals, Psychiatric | 1 | 2017 | 321 | 0.130 |
Why?
|
Taurine | 1 | 2016 | 93 | 0.130 |
Why?
|
Self-Injurious Behavior | 1 | 2022 | 566 | 0.130 |
Why?
|
Psychophysics | 1 | 2016 | 292 | 0.120 |
Why?
|
Personality | 1 | 2019 | 554 | 0.120 |
Why?
|
Emotions | 2 | 2021 | 2738 | 0.120 |
Why?
|
Student Health Services | 1 | 2014 | 40 | 0.120 |
Why?
|
Mood Disorders | 2 | 2011 | 1127 | 0.120 |
Why?
|
Consensus | 2 | 2022 | 3122 | 0.120 |
Why?
|
Cause of Death | 2 | 2022 | 3685 | 0.120 |
Why?
|
Pain Perception | 1 | 2016 | 196 | 0.120 |
Why?
|
Mental Health Services | 2 | 2020 | 1730 | 0.120 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 2 | 2011 | 1988 | 0.110 |
Why?
|
Withholding Treatment | 1 | 2018 | 617 | 0.110 |
Why?
|
Behavior, Animal | 1 | 2022 | 1878 | 0.110 |
Why?
|
Abdominal Pain | 1 | 2020 | 1071 | 0.110 |
Why?
|
Psychological Techniques | 1 | 2013 | 48 | 0.110 |
Why?
|
Personality Assessment | 2 | 2013 | 650 | 0.110 |
Why?
|
Learning | 2 | 2022 | 1740 | 0.110 |
Why?
|
Avoidance Learning | 2 | 2014 | 248 | 0.110 |
Why?
|
Naltrexone | 1 | 2016 | 317 | 0.110 |
Why?
|
Restless Legs Syndrome | 1 | 2016 | 233 | 0.110 |
Why?
|
Attitude to Computers | 1 | 2014 | 196 | 0.110 |
Why?
|
Task Performance and Analysis | 2 | 2022 | 761 | 0.100 |
Why?
|
Psychotherapy, Brief | 1 | 2013 | 118 | 0.100 |
Why?
|
Self Concept | 1 | 2018 | 1043 | 0.100 |
Why?
|
Disabled Persons | 1 | 2022 | 1225 | 0.100 |
Why?
|
Urinalysis | 1 | 2014 | 368 | 0.100 |
Why?
|
Hippocampus | 1 | 2025 | 3763 | 0.100 |
Why?
|
Residence Characteristics | 1 | 2022 | 2092 | 0.100 |
Why?
|
Suicidal Ideation | 1 | 2022 | 1444 | 0.100 |
Why?
|
Hyperalgesia | 1 | 2016 | 531 | 0.100 |
Why?
|
Child Abuse | 1 | 2020 | 1075 | 0.100 |
Why?
|
Recurrence | 3 | 2019 | 8470 | 0.100 |
Why?
|
Social Identification | 1 | 2012 | 108 | 0.100 |
Why?
|
Survivors | 1 | 2022 | 2370 | 0.090 |
Why?
|
Risk | 2 | 2016 | 9605 | 0.090 |
Why?
|
Perceptual Defense | 1 | 2010 | 5 | 0.090 |
Why?
|
Reminder Systems | 1 | 2014 | 388 | 0.090 |
Why?
|
Stroop Test | 1 | 2010 | 71 | 0.090 |
Why?
|
Linguistics | 1 | 2011 | 108 | 0.090 |
Why?
|
Pandemics | 2 | 2021 | 8635 | 0.090 |
Why?
|
Drug Users | 1 | 2012 | 134 | 0.090 |
Why?
|
Bulimia | 1 | 2013 | 400 | 0.090 |
Why?
|
Cell Nucleus | 1 | 2019 | 2909 | 0.090 |
Why?
|
Marketing of Health Services | 1 | 2011 | 150 | 0.090 |
Why?
|
Ambulatory Care | 1 | 2021 | 2775 | 0.090 |
Why?
|
Alprazolam | 1 | 2010 | 102 | 0.090 |
Why?
|
Clonazepam | 1 | 2010 | 135 | 0.090 |
Why?
|
Follow-Up Studies | 7 | 2019 | 39108 | 0.090 |
Why?
|
Clinical Trials as Topic | 3 | 2015 | 7999 | 0.080 |
Why?
|
Antimetabolites | 1 | 2008 | 128 | 0.080 |
Why?
|
Anticonvulsants | 1 | 2018 | 1906 | 0.080 |
Why?
|
Mental Recall | 2 | 2010 | 1214 | 0.070 |
Why?
|
Reaction Time | 2 | 2010 | 2080 | 0.070 |
Why?
|
Social Environment | 1 | 2012 | 1020 | 0.070 |
Why?
|
State Government | 1 | 2010 | 384 | 0.070 |
Why?
|
Tobacco Use Disorder | 1 | 2012 | 703 | 0.070 |
Why?
|
Health Personnel | 1 | 2020 | 3335 | 0.070 |
Why?
|
Parents | 1 | 2020 | 3564 | 0.070 |
Why?
|
Mental Health | 1 | 2020 | 3248 | 0.060 |
Why?
|
HIV Infections | 1 | 2012 | 17346 | 0.060 |
Why?
|
Sex Distribution | 1 | 2010 | 2281 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2013 | 10764 | 0.060 |
Why?
|
Choice Behavior | 1 | 2011 | 824 | 0.060 |
Why?
|
United States Department of Veterans Affairs | 1 | 2010 | 928 | 0.060 |
Why?
|
Pattern Recognition, Visual | 1 | 2010 | 820 | 0.060 |
Why?
|
Memory, Long-Term | 1 | 2025 | 59 | 0.060 |
Why?
|
Massachusetts | 1 | 2017 | 8837 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2019 | 12787 | 0.060 |
Why?
|
Social Support | 1 | 2014 | 2172 | 0.060 |
Why?
|
Secondary Prevention | 3 | 2022 | 1474 | 0.060 |
Why?
|
Telemedicine | 1 | 2021 | 3041 | 0.060 |
Why?
|
Odds Ratio | 1 | 2016 | 9639 | 0.060 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2024 | 303 | 0.050 |
Why?
|
Child | 4 | 2020 | 80156 | 0.050 |
Why?
|
Synaptic Transmission | 1 | 2009 | 1172 | 0.050 |
Why?
|
Personality Disorders | 1 | 2008 | 722 | 0.050 |
Why?
|
Gene Frequency | 1 | 2010 | 3639 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3080 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3200 | 0.050 |
Why?
|
Incidence | 1 | 2020 | 21336 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2022 | 58946 | 0.050 |
Why?
|
Cognition | 2 | 2021 | 6987 | 0.050 |
Why?
|
Rats | 3 | 2025 | 23729 | 0.050 |
Why?
|
Time Factors | 4 | 2019 | 39974 | 0.050 |
Why?
|
Lung | 1 | 2020 | 9994 | 0.050 |
Why?
|
Quality of Life | 2 | 2022 | 13355 | 0.050 |
Why?
|
Gender Identity | 1 | 2007 | 766 | 0.050 |
Why?
|
Yersinia enterocolitica | 1 | 2020 | 13 | 0.050 |
Why?
|
Prognosis | 2 | 2019 | 29588 | 0.050 |
Why?
|
Risk Factors | 3 | 2018 | 74152 | 0.040 |
Why?
|
Galantamine | 1 | 2020 | 33 | 0.040 |
Why?
|
Homicide | 1 | 2022 | 294 | 0.040 |
Why?
|
Naloxone | 1 | 2022 | 370 | 0.040 |
Why?
|
Attitude of Health Personnel | 1 | 2013 | 3889 | 0.040 |
Why?
|
Memory | 1 | 2008 | 2187 | 0.040 |
Why?
|
Feeding Behavior | 1 | 2011 | 3187 | 0.040 |
Why?
|
Alleles | 1 | 2010 | 6909 | 0.040 |
Why?
|
Endpoint Determination | 1 | 2021 | 590 | 0.040 |
Why?
|
Capacity Building | 1 | 2020 | 258 | 0.040 |
Why?
|
Sputum | 1 | 2020 | 506 | 0.040 |
Why?
|
Developed Countries | 1 | 2020 | 449 | 0.040 |
Why?
|
Carbamazepine | 1 | 2018 | 224 | 0.040 |
Why?
|
Students | 2 | 2020 | 1741 | 0.040 |
Why?
|
Poisson Distribution | 1 | 2018 | 504 | 0.040 |
Why?
|
Policy | 1 | 2021 | 508 | 0.030 |
Why?
|
Longitudinal Studies | 3 | 2019 | 14597 | 0.030 |
Why?
|
Violence | 1 | 2022 | 937 | 0.030 |
Why?
|
Animals | 5 | 2025 | 168388 | 0.030 |
Why?
|
Health Status | 1 | 2008 | 4075 | 0.030 |
Why?
|
Synapses | 1 | 2025 | 1769 | 0.030 |
Why?
|
Universities | 1 | 2020 | 994 | 0.030 |
Why?
|
Cost-Benefit Analysis | 1 | 2007 | 5492 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2021 | 2426 | 0.030 |
Why?
|
Health Care Costs | 1 | 2007 | 3243 | 0.030 |
Why?
|
Aftercare | 1 | 2020 | 913 | 0.030 |
Why?
|
Neural Pathways | 1 | 2025 | 3057 | 0.030 |
Why?
|
Classification | 1 | 2013 | 127 | 0.030 |
Why?
|
Diarrhea | 1 | 2020 | 1319 | 0.030 |
Why?
|
Natural Language Processing | 1 | 2022 | 1162 | 0.030 |
Why?
|
Forecasting | 1 | 2022 | 2928 | 0.030 |
Why?
|
Pregnancy | 1 | 2014 | 29858 | 0.030 |
Why?
|
Population Surveillance | 1 | 2022 | 2603 | 0.020 |
Why?
|
Uncertainty | 1 | 2014 | 754 | 0.020 |
Why?
|
Trail Making Test | 1 | 2008 | 57 | 0.020 |
Why?
|
Relaxation Therapy | 1 | 2010 | 181 | 0.020 |
Why?
|
Developing Countries | 1 | 2020 | 2887 | 0.020 |
Why?
|
Critical Care | 1 | 2020 | 2697 | 0.020 |
Why?
|
Somatoform Disorders | 1 | 2010 | 423 | 0.020 |
Why?
|
Desensitization, Psychologic | 1 | 2007 | 27 | 0.020 |
Why?
|
Patient Discharge | 1 | 2020 | 3438 | 0.020 |
Why?
|
Facial Expression | 1 | 2010 | 508 | 0.020 |
Why?
|
Semantics | 1 | 2010 | 601 | 0.020 |
Why?
|
Ethanol | 1 | 2012 | 1324 | 0.020 |
Why?
|
Prospective Studies | 2 | 2020 | 54405 | 0.020 |
Why?
|
Neurons | 1 | 2025 | 9458 | 0.020 |
Why?
|
Educational Status | 1 | 2013 | 2520 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 12972 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2020 | 7439 | 0.010 |
Why?
|
Regression Analysis | 1 | 2011 | 6341 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2008 | 4850 | 0.010 |
Why?
|
Internet | 1 | 2011 | 3094 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12450 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42251 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20555 | 0.010 |
Why?
|
Logistic Models | 1 | 2010 | 13251 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2008 | 7045 | 0.010 |
Why?
|
Chronic Disease | 1 | 2010 | 9319 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 23981 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2007 | 18234 | 0.000 |
Why?
|
Hospitalization | 1 | 2006 | 10715 | 0.000 |
Why?
|
Brain | 1 | 2007 | 27103 | 0.000 |
Why?
|